$0.00
1
6
$0.00
1
6
Trader mode: Actionable analysis for identifying opportunities and edge
COMP360 psilocybin - NDA If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before X 1, 2027, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs. This market will close and expire early if the event occurs.
AI-generated analysis based on market data. Not financial advice.
Educational content is AI-generated and sourced from Wikipedia. It should not be considered financial advice.
6 markets tracked
No data available
| Market | Platform | Price |
|---|---|---|
When will COMPASS Pathways plc submit a NDA for COMP360 psilocybin to the FDA? (before April 2027) | Kalshi | 80% |
When will COMPASS Pathways plc submit a NDA for COMP360 psilocybin to the FDA? (before 2027) | Kalshi | 75% |
When will COMPASS Pathways plc submit a NDA for COMP360 psilocybin to the FDA? (before December) | Kalshi | 59% |
When will COMPASS Pathways plc submit a NDA for COMP360 psilocybin to the FDA? (before November) | Kalshi | 41% |
When will COMPASS Pathways plc submit a NDA for COMP360 psilocybin to the FDA? (before October) | Kalshi | 16% |
When will COMPASS Pathways plc submit a NDA for COMP360 psilocybin to the FDA? (before September) | Kalshi | 8% |
No related news found
Add this market to your website
<iframe src="https://predictpedia.com/embed/r5u4aP" width="400" height="160" frameborder="0" style="border-radius: 8px; max-width: 100%;" title="When will Compass Pathways submit a NDA for COMP360 psilocybin?"></iframe>